New Key Statistics Module, Z-Score and F-Score
SZSE:300937 Key Ratios
Market Cap ¥ M | 2,187.90 |
Enterprise Value ¥ M | 2,229.48 |
P/E(ttm) | 59.25 |
PE Ratio without NRI | 45.65 |
Forward PE Ratio | -- |
Price/Book | 2.53 |
Price/Sales | 0.48 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 181.51 |
Payout Ratio % | 0.40 |
Revenue (TTM) ¥ M | 4,545.00 |
EPS (TTM) ¥ | 0.39 |
Beneish M-Score | -2.1 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -8.30 |
y-y EBITDA Growth Rate % | -32.60 |
EV-to-EBIT | 43.94 |
EV-to-EBITDA | 43.94 |
PEG | -- |
Shares Outstanding M | 95.67 |
Net Margin (%) | 0.82 |
Operating Margin % | 1.44 |
Pre-tax Margin (%) | 0.92 |
Quick Ratio | 1.06 |
Current Ratio | 1.55 |
ROA % (ttm) | 2.21 |
ROE % (ttm) | 4.37 |
ROIC % (ttm) | 5.86 |
Dividend Yield % | 0.89 |
Altman Z-Score | 4.18 |
SZSE:300937 Number of Guru Trades
SZSE:300937 Volume of Guru Trades
Gurus Latest Trades with SZSE:300937
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300937 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd Insider Transactions
No Available Data